Abstract |
Ursodeoxycholic acid (3 alpha,7 beta-dihydroxy-5 beta- cholanoic acid, UDCA) is a therapeutically applicable bile acid widely used for the dissolution of cholesterol-rich gallstones and in the treatment of chronic liver diseases associated with cholestasis. UDCA is more hydrophilic and less toxic than another therapeutically valuable bile acid, chenodeoxycholic acid (CDCA), the 7 alpha-epimer of UDCA. Procedures for sample preparation and HPLC determination of UDCA in blood serum were developed and validated. A higher homologue of UDCA containing an additional methylene group in the side chain was synthetized and used as an internal standard (IS). Serum samples with IS were diluted with a buffer (pH=7). The bile acids and IS were captured using solid phase extraction (C18 cartridges). The carboxylic group of the analytes was derivatized using 2-bromo-2'-acetonaphthone (a detection-oriented derivatization), and reaction mixtures were analyzed (HPLC with UV 245 nm detection; a 125--4 mm column containing Lichrospher 100 C18, 5 microm; mobile phase: acetonitrile--water, 6:4 (v/v)). Following validation, this method was used for pharmacokinetic studies of UDCA in humans.
|
Authors | M Nobilis, M Pour, J Kunes, J Kopecký, J Kvĕtina, Z Svoboda, K Sládková, J Vortel |
Journal | Journal of pharmaceutical and biomedical analysis
(J Pharm Biomed Anal)
Vol. 24
Issue 5-6
Pg. 937-46
(Mar 2001)
ISSN: 0731-7085 [Print] England |
PMID | 11248487
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Chromatography, High Pressure Liquid
(methods)
- Female
- Humans
- Male
- Pilot Projects
- Reference Standards
- Reference Values
- Reproducibility of Results
- Spectrophotometry, Ultraviolet
- Ursodeoxycholic Acid
(blood, pharmacokinetics)
|